drugset / Trial / NCT01523106

L-carnitine to Treat Fatigue Associated With Crohn's Disease

NCT01523106

RandomizedSingle-groupDouble-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled study, comparing the effect of L-carnitine vs placebo on fatigue among Crohn's disease patients. The specific aim of this study is to determine if treatment with L-carnitine is more effective than placebo at decreasing fatigue severity scores, while accounting for disease activity and concomitant anemia, depression/anxiety and poor sleep quality.

Timeline

Start
2013-08
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator L-carnitine Other / unclassified 2 g

Indications